These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15615636)

  • 1. Pathways of tau fibrillization.
    Kuret J; Chirita CN; Congdon EE; Kannanayakal T; Li G; Necula M; Yin H; Zhong Q
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):167-78. PubMed ID: 15615636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.
    Gamblin TC; Chen F; Zambrano A; Abraha A; Lagalwar S; Guillozet AL; Lu M; Fu Y; Garcia-Sierra F; LaPointe N; Miller R; Berry RW; Binder LI; Cryns VL
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):10032-7. PubMed ID: 12888622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 4. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
    Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P
    J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating triggers and enhancers of tau fibrillization.
    Kuret J; Congdon EE; Li G; Yin H; Yu X; Zhong Q
    Microsc Res Tech; 2005 Jul; 67(3-4):141-55. PubMed ID: 16103995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.
    Wilson DM; Binder LI
    Am J Pathol; 1997 Jun; 150(6):2181-95. PubMed ID: 9176408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.
    Baglietto-Vargas D; Kitazawa M; Le EJ; Estrada-Hernandez T; Rodriguez-Ortiz CJ; Medeiros R; Green KN; LaFerla FM
    Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro tau fibrillization: mapping protein regions.
    Santa-María I; Pérez M; Hernández F; Muñoz V; Moreno FJ; Avila J
    Biochim Biophys Acta; 2006 Jul; 1762(7):683-92. PubMed ID: 16891100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alzheimer's disease: cellular and molecular aspects].
    Octave JN; Pierrot N
    Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and Alzheimer's disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein.
    Hategan A; Masliah E; Nath A
    J Neurovirol; 2019 Oct; 25(5):648-660. PubMed ID: 31016584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MARKing tau for tangles and toxicity.
    Drewes G
    Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an intermediate in tau filament formation.
    Chirita CN; Kuret J
    Biochemistry; 2004 Feb; 43(6):1704-14. PubMed ID: 14769048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.
    Castellani RJ; Lee HG; Perry G; Smith MA
    Am J Alzheimers Dis Other Demen; 2006; 21(2):126-30. PubMed ID: 16634469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau phosphorylation and assembly.
    Gómez-Ramos A; Smith MA; Perry G; Avila J
    Acta Neurobiol Exp (Wars); 2004; 64(1):33-9. PubMed ID: 15190678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Conformation of Tau Protein Mapped by Raman Spectroscopy.
    Gorantla NV; Khandelwal P; Poddar P; Chinnathambi S
    Methods Mol Biol; 2017; 1523():21-31. PubMed ID: 27975242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.